XAF1 as a modifier of p53 function and cancer susceptibility

Journal: Science Advances

Published: 2020-06-01

DOI: 10.1126/sciadv.aba3231

Affiliations: 29

Authors: 64

Go to article
Institutions Share
NIH National Cancer Institute (NCI), United States of America (USA) 0.13
School of Medicine, USP, Brazil 0.08
Instituto de Pesquisa Pelé Pequeno Príncipe, Brazil 0.06
Department of Oncology, St. Jude, United States of America (USA) 0.06
Department of Pathology, St. Jude, United States of America (USA) 0.06
Barretos Cancer Hospital, Brazil 0.06
Center for Applied Bioinformatics (CAB), St. Jude, United States of America (USA) 0.06
A.C. Camargo Cancer Center (CIPE), Brazil 0.05
Federal University of Rio Grande do Sul (UFRGS), Brazil 0.03
Federal University of Paraná (UFPR), Brazil 0.03
Center for Advanced Genome Engineering (CAGE), St. Jude, United States of America (USA) 0.03
UCL Research Department of Genetics, Evolution and Environment (GEE), United Kingdom (UK) 0.03
Sant Joan de Déu Research Institute (IRSJD), Spain 0.03
Department of Global Pediatric Medicine, St. Jude, United States of America (USA) 0.03
University of Michigan (U-M), United States of America (USA) 0.03
Centre for Endocrinology, QMUL, United Kingdom (UK) 0.02
Institute of Molecular and Cellular Pharmacology (IPMC), France 0.02
Department of Surgery, St. Jude, United States of America (USA) 0.02
Hospital do Câncer de Cascavel (UOPECCAN), Brazil 0.02
Cordelier Research Center (CRC), France 0.02
Centre François Baclesse, France 0.02
Hospital Sírio-Libanês, Brazil 0.02
Perelman School of Medicine, Penn, United States of America (USA) 0.02
Institute Gustave-Roussy (IGR), France 0.02
Department of Pediatrics, USP, Brazil 0.02
Hospital Universitario Virgen de la Arrixaca, Spain 0.02
Hospital Infantil Joana de Gusmão, Brazil 0.02
Federal University of Bahia (UFBA), Brazil 0.02
Hartwell Center for Bioinformatics and Biotechnology, St. Jude, United States of America (USA) 0.02

Return